News

Officials at the Wisconsin Alumni Research Foundation (WARF) noted that this licensing agreement with BioTime demonstrates that commercial interest in human embryonic stem cells remains strong. With this

The Combinatorial Chemistry Center of the chemistry department of Moscow State University (MSU) has agreed to apply its expertise to provide Upstream with drug candidates for in vivo

DG051 was shown to reduce the production of leukotriene B4 (LTB4) in a dose-dependent manner. The results of the study confirm that DG051 shows reductions in LTB4 in

Morphotek will apply its proprietary Morphodoma antibody technology for the development of novel therapeutic antibodies for use in the treatment of prostate cancer. The NCI will provide its

AcerMed provides comprehensive and advanced electronic medical records (EMR) and practice management software solutions for a range of medical practices, from solo practitioners to multi-site, multi-specialty group practices

Based on the results of this study and a review of such results with its consultant toxicologists, Somaxon intends to proceed with the submission of a new drug

The company said that the funding will help Arcion continue its breakthrough work with ARC-4558, a topical clonidine gel for alleviating moderate and severe pain associated with diabetic

Barr filed an abbreviated new drug application containing a paragraph IV certification for a generic Eloxatin product with the FDA, and following FDA notification of the application’s acceptance

The new offering, called Clarient Insight Dx breast cancer profile, will be sold by Clarient through an exclusive license agreement with Prediction Sciences. The profile is a series